Bay Area biotech company says it's using AI to make cell therapy more accessible

From hiking to running marathons, Laurie Adami makes the most of the time she has here on Earth."I did the LA Marathon in 2021," she said. "I did the Washington D.C. Marine Corps Marathon in 2022."There was a point, however, where she expected her life would come to an early end."I remember it very well," she said.It was Good Friday, 2006. Adami was diagnosed with stage 4 follicular non-Hodgkin lymphoma."It's like a bomb exploding in your head," she said. "From 2006 until 2018, I was in continuous treatment, and we could never get my disease to go away."Nothing was working. Adami felt like she was nearing the end."I was within probably four to six weeks of dying," she said.But then, an experimental treatment worked."Cell therapy saved my life," she said.In the simplest of explanations, cell therapy uses living cells to treat diseases. They're taken from either healthy donors or the patients, and then grown, altered, or engineered, to be delivered back into the patient's body.Cell thera